What the Most Successful Drug Launches Reveal About Modern Pharma IP, Pricing, and Market Strategy
Recent successful drug launches indicate a trend toward more specialized, high-priced drugs that treat less-common medical conditions.
February 2019
US Drug Spending: Where $603 Billion Goes, How IP Architecture Shapes Every Dollar, and What It Means for Pharma Investors
Prescription drugs are expensive to develop, and many intermediaries stand between patients and drug makers. Here’s where the money goes.
